Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.68 USD | +3.86% | -11.74% | -31.43% |
08/05 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/04 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.43% | 521M | |
+22.78% | 44.96B | |
+1.13% | 42.65B | |
+45.83% | 41.85B | |
-4.27% | 29.04B | |
+11.18% | 26.08B | |
-21.29% | 19.03B | |
+6.60% | 12.75B | |
+28.48% | 12.06B | |
-4.26% | 11.75B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- Olema Pharmaceuticals Insider Sold Shares Worth $209,296, According to a Recent SEC Filing